Fletcher; Sue

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fletcher; Sue.The latest application filed is for "novel retinitis pigmentosa treatment".

Company Profile

22.48.61

Fletcher; Sue - Bayswater WA
FLETCHER; Sue - Murdoch AU
Fletcher; Sue - Western Australia AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Retinitis Pigmentosa Treatment App 20220298506 - Fletcher; Sue ; et al.	2022-09-22
Antisense molecules and methods for treating pathologies Grant 11,447,776 - Wilton , et al. September 20, 2	2022-09-20
Antisense-induced Exon2 Inclusion In Acid Alpha-glucosidase App 20220170024 - WILTON; Stephen Donald ; et al.	2022-06-02
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant RE48,960 - Wilton , et al. March 8, 2	2022-03-08
Antisense-induced exon2 inclusion in acid alpha-glucosidase Grant 11,236,338 - Wilton , et al. February 1, 2	2022-02-01
Novel Treatment For Neat1 Associated Disease App 20210355489 - Wilton; Stephen Donald ; et al.	2021-11-18
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20210198666 - WILTON; Stephen Donald ; et al.	2021-07-01
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 10,995,337 - Wilton , et al. May 4, 2	2021-05-04
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 10,968,450 - Wilton , et al. April 6, 2	2021-04-06
Antisense Molecules And Methods For Treatng Patholgies App 20210040482 - WILTON; Stephan Donald ; et al.	2021-02-11
Antisense molecules and methods for treating pathologies Grant 10,781,450 - Wilton , et al. Sept	2020-09-22
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 10,781,451 - Wilton , et al. Sept	2020-09-22
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20200283772 - Wilton; Stephen Donald ; et al.	2020-09-10
Restoration of the CFTR function by splicing modulation Grant 10,731,156 - Kerem , et al.	2020-08-04
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20200199590 - WILTON; Stephen Donald ; et al.	2020-06-25
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant RE47,769 - Wilton , et al. Dec	2019-12-17
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant RE47,751 - Wilton , et al. De	2019-12-03
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant RE47,691 - Wilton , et al. No	2019-11-05
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20190323010 - Wilton; Stephen Donald ; et al.	2019-10-24
Restoration of the CFTR function by splicing modulation Grant 10,428,328 - Kerem , et al. October 1, 2	2019-10-01
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 10,421,966 - Wilton , et al. Sept	2019-09-24
Antisense Molecules And Methods For Treating Pathologies App 20190270994 - WILTON; Stephen Donald ; et al.	2019-09-05
Multiple sclerosis treatment Grant 10,376,536 - Wilton , et al. A	2019-08-13
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20190144861 - Wilton; Stephen Donald ; et al.	2019-05-16
Antisense molecules and methods for treating pathologies Grant 10,287,586 - Wilson , et al.	2019-05-14
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 10,266,827 - Wilton , et al.	2019-04-23
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 10,227,590 - Wilton , et al.	2019-03-12
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20190062742 - WILTON; Stephen Donald ; et al.	2019-02-28
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20180371458 - WILTON; Stephen Donald ; et al.	2018-12-27
Antisense-induced Exon2 Inclusion In Acid Alpha-glucosidase App 20180216111 - WILTON; Stephen Donald ; et al.	2018-08-02
Antisense Molecules And Methods For Treating Pathologies App 20180171333 - Wilton; Stephen Donald ; et al.	2018-06-21
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20180163205 - WILTON; Stephen Donald ; et al.	2018-06-14
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,994,851 - Wilton , et al. June 12, 2	2018-06-12
Restoration Of The Cftr Function By Splicing Modulation App 20180155723 - KEREM; Batsheva ; et al.	2018-06-07
Multiple Sclerosis Treatment App 20180104273 - Wilton; Stephen Donald ; et al.	2018-04-19
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20180051282 - WILTON; Stephen Donald ; et al.	2018-02-22
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20180002697 - WILTON; Stephen Donald ; et al.	2018-01-04
Antisense molecules and methods for treating pathologies Grant 9,758,783 - Wilton , et al. September 12, 2	2017-09-12
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,605,262 - Wilton , et al. March 28, 2	2017-03-28
Antisense Oligomers And Methods For Treating Smn-related Pathologies App 20170051277 - Wilton; Stephen Donald ; et al.	2017-02-23
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20170009234 - WILTON; Stephen Donald ; et al.	2017-01-12
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20170009233 - WILTON; Stephen Donald ; et al.	2017-01-12
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,447,415 - Wilton , et al. September 20, 2	2016-09-20
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,441,229 - Wilton , et al. September 13, 2	2016-09-13
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,422,555 - Wilton , et al. August 23, 2	2016-08-23
Antisense-induced Exon2 Inclusion In Acid Alpha-glucosidase App 20160208264 - Wilton; Stephen Donald ; et al.	2016-07-21
Antisense Molecules And Methods For Treating Pathologies App 20160177301 - Wilton; Stephen Donald ; et al.	2016-06-23
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,249,416 - Wilton , et al. February 2, 2	2016-02-02
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20160002635 - Wilton; Stephen Donald ; et al.	2016-01-07
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20160002632 - Wilton; Stephen Donald ; et al.	2016-01-07
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20160002631 - Wilton; Stephen Donald ; et al.	2016-01-07
Antisense molecules and methods for treating pathologies Grant 9,228,187 - Wilton , et al. January 5, 2	2016-01-05
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20150376616 - Wilton; Stephen Donald ; et al.	2015-12-31
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20150376615 - Wilton; Stephen Donald ; et al.	2015-12-31
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20150353931 - Wilton; Stephen Donald ; et al.	2015-12-10
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,175,286 - Wilton , et al. November 3, 2	2015-11-03
Restoration Of The CFTR Function By Splicing Modulation App 20150211010 - Kerem; Batsheva ; et al.	2015-07-30
Antisense-induced Exon2 Inclusion In Acid Alpha-glucosidase App 20150197534 - Wilton; Stephen Donald ; et al.	2015-07-16
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,035,040 - Wilton , et al. May 19, 2	2015-05-19
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,024,007 - Wilton , et al. May 5, 2	2015-05-05
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 9,018,368 - Wilton , et al. April 28, 2	2015-04-28
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20150057330 - Wilton; Stephen Donald ; et al.	2015-02-26
Antisense Molecules And Methods For Treating Pathologies App 20140350067 - Wilton; Stephen Donald ; et al.	2014-11-27
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140309283 - Wilton; Stephen Donald ; et al.	2014-10-16
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140309285 - WILTON; Stephen Donald ; et al.	2014-10-16
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140309284 - Wilton; Stephen Donald ; et al.	2014-10-16
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140243516 - WILTON; Stephen Donald ; et al.	2014-08-28
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140243515 - WILTON; Stephen Donald ; et al.	2014-08-28
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140155587 - WILTON; Stephen Donald ; et al.	2014-06-05
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20140080898 - Wilton; Stephen Donald ; et al.	2014-03-20
Antisense molecules and methods for treating pathologies Grant 8,637,483 - Wilton , et al. January 28, 2	2014-01-28
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20130331438 - WILTON; Stephen Donald ; et al.	2013-12-12
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20130274313 - WILTON; Stephen Donald ; et al.	2013-10-17
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20130253033 - WILTON; Stephen Donald ; et al.	2013-09-26
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20130253180 - WILTON; Stephen Donald ; et al.	2013-09-26
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,524,880 - Wilton , et al. September 3, 2	2013-09-03
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20130217755 - WILTON; Stephen Donald ; et al.	2013-08-22
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,486,907 - Wilton , et al. July 16, 2	2013-07-16
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,476,423 - Wilton , et al. July 2, 2	2013-07-02
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,455,634 - Wilton , et al. June 4, 2	2013-06-04
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,455,636 - Wilton , et al. June 4, 2	2013-06-04
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,455,635 - Wilton , et al. June 4, 2	2013-06-04
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,450,474 - Wilton , et al. May 28, 2	2013-05-28
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20130116310 - Wilton; Stephen Donald ; et al.	2013-05-09
Antisense Molecules And Methods For Treating Pathologies App 20120270925 - Wilton; Stephen Donald ; et al.	2012-10-25
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 8,232,384 - Wilton , et al. July 31, 2	2012-07-31
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20120041050 - Wilton; Stephen Donald ; et al.	2012-02-16
Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof App 20120029059 - Wilton; Stephen Donald ; et al.	2012-02-02
Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof App 20120029057 - Wilton; Stephen Donald ; et al.	2012-02-02
Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof App 20120029060 - Wilton; Stephen Donald ; et al.	2012-02-02
Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof App 20120029058 - Wilton; Stephen Donald ; et al.	2012-02-02
Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof App 20120022144 - Wilton; Stephen Donald ; et al.	2012-01-26
Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof App 20120022145 - Wilton; Stephen Donald ; et al.	2012-01-26
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20110263686 - WILTON; STEPHEN DONALD ; et al.	2011-10-27
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 7,960,541 - Wilton , et al. June 14, 2	2011-06-14
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20110046203 - Wilton; Stephen Donald ; et al.	2011-02-24
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20110015253 - Wilton; Stephen Donald ; et al.	2011-01-20
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use Thereof App 20110015258 - Wilton; Stephen Donald ; et al.	2011-01-20
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant 7,807,816 - Wilton , et al. October 5, 2	2010-10-05
Antisense Oligonucleotides For Inducing Exon Skipping and Methods of Use Thereof App 20080200409 - Wilson; Stephen Donald ; et al.	2008-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.